AstraZeneca Pharma India files SEBI compliance certificate
AstraZeneca Pharma India files SEBI Regulation 74(5) compliance certificate. This routine disclosure confirms adherence to shareholding pattern reporting norms. No financial or operational impact is indicated. The filing is part of standard regulatory compliance.
📊 STOCKS: $ASTRAZEN | 🏢 SECTOR: Pharma | #LOWIMPACT #SEBI
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.